Clinical trial
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating…
NCT00003400 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00003400 |
|---|---|
| Title | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer |
| Official title | High Dose Chemotherapy With Stem Cell Rescue Followed By Consolidation Treatment in Patients With Metastatic Hormone-Refractory Prostate Cancer |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carmustine, cisplatin, melphalan, vinorelbine tartrate, peripheral blood stem cell transplantation |
| Enrollment | 45 |
| Start date | Sep 1, 1998 |
| Primary completion | Mar 1, 2000 |
| Completion | Mar 1, 2000 |
| First posted | Aug 16, 2004 |
| Last update posted | Nov 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: